Als-Con-201 Salesforce Certified Agentforce Life Sciences Consultant Questions and Answers

The correct answer is B because the deadlines and review windows for activity-plan adjustments are configured on the Activity Plan record, specifically in the review-related configuration. Salesforce Help for creating Activity Plans references fields such as Reviewer Plan Adjustment Start Date and Reviewer Plan Adjustment End Date , which define the date range in which the manager can review adjustment requests.

The scenario describes a plan-level governance requirement: field sales reps must submit proposed visit targets by a specific deadline, and adjustments above allowed thresholds must be reviewed. This belongs to the Activity Plan configuration because the plan defines the cycle, timing, targets, review process, and adjustment behavior for the territory or provider planning period. Configuring the Review Details section ensures that the plan controls when reps can submit changes and when managers can review them.

Option A is incorrect because Global Calculation Settings for a Provider Activity Measure Type would relate to how measures or calculations are evaluated, not the submission and manager-review deadline for a specific Activity Plan. Option C is also incorrect because a Goal Definition represents a reusable planning objective, but it does not control the operational review dates and adjustment thresholds for a specific West Coast Activity Plan. Therefore, the consultant should configure the deadlines and adjustment limits on the Activity Plan record within the Review Details section .

=========

Option B is correct because Salesforce Life Sciences Cloud requires a specific API-name prefix for custom Lightning web components that should render as inline components in the Life Sciences mobile app. Salesforce Help for creating and adding an LWC as an inline component on a record page states that admins must create a custom mobile-ready LWC and add lscMobileInline_ as the prefix for the component’s API name. This exact prefix identifies the component as compatible with the Life Sciences mobile inline rendering framework.

This directly matches the issue in the scenario. The component exists and was added to the Account record page, but it does not render correctly as an inline component in the mobile app. The missing configuration is not the page placement itself, but the required naming convention that allows the Life Sciences mobile app to recognize and render the LWC inline.

Option A, lsc_mobile_, is incorrect because it is not the documented prefix for inline mobile LWCs. Option C, mobileInline_, is also incorrect because it omits the Life Sciences-specific lsc prefix and does not match the Salesforce Help requirement. Therefore, the consultant should rename or recreate the LWC API name using the lscMobileInline_ prefix so it functions correctly as an inline component in the Agentforce Life Sciences mobile app.

=========

Option B is correct because Communication Subscription Channel Type is the junction record that links a Communication Subscription to an Engagement Channel Type. Salesforce’s Life Sciences Consent Management data model includes Communication Subscription, Communication Subscription Channel Type, Communication Subscription Consent, Data Use Purpose, Engagement Channel Type, and related consent objects. This confirms that subscription-channel availability is modeled through Communication Subscription Channel Type, not only through the subscription or channel records separately.

Salesforce’s Communication Subscription objects documentation states that Communication Subscription Channel Type specifies the engagement channel that can be used to contact the customer for a communication subscription. The Salesforce object reference also identifies fields on Communication Subscription Channel Type such as EngagementChannelTypeId, confirming that this object connects the subscription to the channel.

Option A is incorrect because there is no indication that a generic “Allow Email Channel” checkbox controls this relationship. Option C is also incorrect because Communication Subscription Consent stores an individual HCP’s consent preference after the channel-subscription combination exists. It does not make the Email channel selectable for the subscription. Therefore, the consultant must create a Communication Subscription Channel Type record linking “Immunexis KOL Webinar Series” to the Email Engagement Channel Type.

The correct answer is B because Life Sciences mobile app configuration changes must be synchronized to the mobile experience through metadata cache generation. Salesforce Help states that configuration changes are synced to the Life Sciences Cloud mobile app by generating a metadata cache, and that the generated metadata cache includes object schemas and related metadata required by the mobile app. Salesforce also states that a new metadata cache should be generated when administrators update Lightning record pages, page layouts, object or schema changes, new or modified feature settings, or related mobile configuration.

In this case, the consultant correctly updated the Account Lists configuration in the Admin Console to use a new Account field set. The reason the app still shows the old Account List layout is that the mobile app has not received the updated metadata. Running the Mobile Metadata Cache update pushes the refreshed configuration to the app so that field sales reps can see the new Account List columns.

Option A is incorrect because the issue is not with the Account Lightning record page. The change was made to Account Lists in the Admin Console, not to the record page layout. Option C is also incorrect because deleting and reinstalling the app is a user-side workaround and does not publish new admin metadata. The proper administrator action is to run the metadata cache update.

=========

Option B, Action Plan Template Assignment, is correct. In Salesforce Life Sciences Cloud Key Account Management, strategic planning uses goal definitions and action plan templates to standardize account-planning execution. A Goal Definition represents the reusable strategic goal blueprint, such as “Secure Formulary Access.” An Action Plan Template defines the repeatable tactical tasks that should be generated when that goal is added to an account plan. The object that connects these two pieces is ActionPlanTemplateAssignment. Salesforce’s Life Sciences Cloud Developer Guide describes ActionPlanTemplateAssignment as the object to which the action plan template is associated, including examples such as a problem definition, goal definition, or care plan template. This directly matches the scenario: the action plan template must be associated with the goal definition so that importing the predefined strategic goal can generate the related tactical action plan.

Option A is not correct because “Action Plan Template Goal” is not the standard object identified in the Salesforce Life Sciences Cloud data model for this association. Option C is also incorrect because an Action Plan Template Participant would relate to participants, not the relationship between a goal definition and an action plan template. Salesforce’s Key Account Management Account Plan data model also includes Action Plan Template Assignment, Action Plan Template, Action Plan Template Item, and Goal Definition as part of the standard account-planning architecture.

Therefore, the correct object for linking the tactical action plan template to the reusable strategic goal definition is Action Plan Template Assignment.

=========

Option B, Product Item, is correct because Salesforce defines ProductItem as the object that represents the stock of a particular product at a particular location. Salesforce Field Service developer documentation states that ProductItem represents stock of a product at a location, such as items stored in a warehouse. The Field Service Inventory Management data model also states that inventory management starts with product items, which represent stock of a particular product at a particular location.

This exactly matches the reporting requirement. The analyst needs to calculate how much “Immunexis 50mg” exists in each sales rep’s trunk. In Salesforce inventory architecture, each rep’s trunk is modeled as a Location, and the stock quantity of a given Product2 at that Location is represented by Product Item records. Reporting on Product Item allows the analyst to group by Location, filter or group by Product, and calculate quantity or value.

Option A, Location Group, is incorrect because a location group organizes or groups locations; it does not represent the actual stock quantity of a specific product at an individual location. Option C, Product Request, is also incorrect because a product request is used for requesting or moving inventory, not for representing the on-hand inventory balance. Therefore, Product Item is the primary data source for this report.

Option C is correct because Medical Insight upvotes are handled through the UserReaction object and related out-of-the-box logic. Salesforce’s Life Sciences Cloud Developer Guide states that UserReaction represents a user’s reaction to a medical insight, such as an upvote or downvote, and that these reactions are used to identify trending insights. This directly supports the scenario because the problem involves duplicate upvotes and the inability to see total upvote counts on Medical Insight records.

Salesforce’s MedicalInsight object documentation also references fields related to ranking and upvotes, including a default rank determined based on linked insights and their upvotes. This confirms that upvote behavior is part of the standard Medical Insights data model rather than something that should be rebuilt manually.

Option A is not the best answer because MedicalInsightValidationHandler sounds focused on validating Medical Insight records generally, not specifically managing user reactions, duplicate reactions, or upvote counts. Option B is also not preferred because custom validation rules and a new roll-up summary field would duplicate behavior that Salesforce provides through the Medical Insights user-reaction framework. The requirement asks for the out-of-the-box configuration, so the consultant should activate the UserReactionMedicalInsightHandler to manage upvote reactions consistently and support the total-count behavior.

=========

Option C is correct because the issue occurs when an HCP joins a Remote Engagement call through an Experience Cloud site link. In this flow, the external HCP typically accesses the site as the Site Guest User, so the guest user needs the correct permission set to use the remote engagement experience. Salesforce Help for creating an Experience Cloud site for Remote Engagement states that admins must assign permission sets to the guest user of the site, including Access Remote Engagement for Digital Experience . This directly matches the error in the question: the HCP reaches the site, but receives an insufficient permissions error.

Option A is incorrect because the Life Sciences Commercial Admin permission set is intended for administrative users, not the Site Guest User serving an unauthenticated Remote Engagement portal. Assigning broad admin permissions to a guest user would also be inappropriate from a security and compliance perspective. Option B is also incorrect because the requirement is not to license the HCP as a Customer Community Plus user. The scenario describes an HCP joining from a link, and the Salesforce setup guidance specifically identifies a permission-set assignment for the Site Guest User.

Therefore, the consultant should assign the Access Remote Engagement for Digital Experience permission set to the Experience Cloud Site Guest User.

=========

Option B is correct because the requirement is specifically to prevent visit creation when a Visit overlaps with a Time Off Territory record. Salesforce Life Sciences documentation references Time Off Territory overlapping rules as the standard mechanism that prevents creating visits during TOT events. Salesforce’s Winter ’26 Customer Engagement package patch notes also mention an issue where a visit could be created during a Time Off Territory event, bypassing the overlapping rule that should have prevented creation. That confirms TOT overlapping rules are the expected standard control for this scenario.

Because the business wants a hard stop, the overlapping rule behavior must be set to “Error.” This means the rep receives an error and cannot proceed with scheduling the visit while it conflicts with the TOT time block.

Option A is incorrect because a custom validation rule on Visit would duplicate a standard Life Sciences calendar/TOT capability and may not handle the full mobile scheduling experience correctly. Option C is also not the best answer because “Block Activity on Conflict” on the TOT record type is not the documented standard configuration in the Life Sciences Visit/Calendar settings. The correct standard configuration is to use TOT Overlapping Rules and set the overlap behavior to Error. This prevents scheduling visits during the rep’s logged time off.

=========

The correct answer is A because Today’s Pace is tied to the Activity Plan’s calculation behavior, not the home page component itself. Salesforce describes Activity Plans as a way to establish a strategic activity plan and define activity goals for sales representatives over a specific period. Salesforce’s Life Sciences Activity Plans developer guidance also describes Activity Plans as allowing administrators to define goals for specific employees, including targeted accounts, plan-cycle duration, activity types, and progress tracking.

When the business wants Today’s Pace calculated based on working days, that logic should be defined where the activity plan is created and governed. Selecting Working Days in the Today’s Pace Calculation Type field ensures the pacing metric uses working-day logic for the plan instead of simply counting all calendar days. This is the correct place to configure the calculation because Today’s Pace reflects plan progress against the plan timeline.

Option B is incorrect because editing the home page component only controls presentation. A component can display the metric, but it should not be the source of the calculation rules for the underlying Activity Plan. Option C is also not the best answer because the requirement is not a broad global enablement setting; it asks how to calculate Today’s Pace for the relevant Activity Plan. Therefore, the consultant should configure the calculation type directly on the Activity Plan by selecting Working Days .

The correct answer is B because the issue is the Activity Plan status transition. Salesforce describes Activity Plans as the mechanism to establish strategic plans and define activity goals for sales representatives over a specific period. The Life Sciences Activity Plans developer guidance also explains that activity plans define goals for employees, including targeted accounts, plan-cycle duration, activity types, and progress tracking.

In this scenario, the plan exists and has a Start Date of today, but it is still in In Progress status. Reps cannot see the plan or their targets because the plan has not moved into the operational Active state. The specific job designed for this is Update Activity Plan Status , which evaluates the plan’s dates and moves eligible plans from In Progress to Active. Running that job makes the plan available for execution and dashboard reporting.

Option A is incorrect because Activity Plan Trigger Handler suggests trigger-based automation, not the named batch process that transitions plan status according to dates. Option C, Validate Activity Plans , is also incorrect because validation checks whether the plan setup is correct; it does not perform the status transition required by the question. The consultant should run Update Activity Plan Status in the Admin Console.

=========

The correct answer is A from the available options, because the requirement is to control which user actions are exposed to different roles during the Medical Inquiry lifecycle. Salesforce Help for Medical Inquiries states that organizations can define relevant workflow actions for tasks users perform in the medical inquiry process, such as inquiry submission and assignment. Salesforce also describes a compliant role separation where field sales reps can submit medical inquiries, while Medical Science Liaisons can assign and respond to them.

The ideal Salesforce Life Sciences configuration pattern is to use Medical Inquiry workflow actions and workflow paths to control status transitions, actions, and permissions. However, among the provided answer choices, record types with role-specific page layouts is the only option that directly supports restricting the available buttons and actions by user role. This enables sales users to see only draft, sign, and submit actions, while MSL users see only assignment and response actions.

Option B is incorrect because a formula field can calculate or display logic, but it cannot enforce workflow actions or user interaction permissions by itself. Option C is also incorrect because a Flow action could add custom logic, but it is not the standard configuration approach for restricting Medical Inquiry lifecycle actions. Therefore, the best available answer is A .

=========

The correct answer is B because the requirement combines two controls: a territory-level cap for a product during a defined period and a per-visit disbursement limit for sales reps. Salesforce Life Sciences documentation for Territory Product Quantity Allocations states that these allocations are used to manage sample product distribution to healthcare professionals, and the setup guidance specifically references the Max Disbursement Limit Quantity as the maximum amount a sales rep can disburse in a given visit.

A Territory Product Quantity Allocation record is designed for the exact scenario described: controlling how much of a specific product is allocated to a territory and limiting how much can be disbursed during a visit. The consultant would define the allocated quantity for Immunexis 50mg for the high-growth territory for the next quarter and set the Max Disbursement Limit Quantity to 50 so that an individual field sales rep cannot hand off more than 50 units in one visit.

Option A is incorrect because setting a product-level maximum sample order quantity would apply too broadly across the organization and would not satisfy the territory-specific allocation requirement. Option C is not the best answer because an Advanced Sample Limit Template at the Healthcare Provider account level controls limits by HCP/account, not the total quantity available to a territory. Therefore, Territory Product Quantity Allocation is the correct administrative configuration.

Option C is correct because Life Sciences Cloud separates the overall visit activity from provider-specific visit details. In the Life Sciences Cloud data model, the Visit object tracks information related to a field representative’s visit to a healthcare provider and is used for Customer Engagement. Salesforce’s ProviderVisit object represents the details of a field user’s visit to a healthcare provider. The Customer Engagement data model also explains that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples.

For a group visit such as a “Lunch and Learn” with three HCPs, the overall event is represented by the parent Visit record. Each attendee requires their own provider-specific visit detail record because each HCP may have different product discussions, messages, samples, signatures, or follow-up activities. Therefore, the system creates one parent Visit and separate child Provider Visit records for each HCP attendee.

Option A is incorrect because a multi-select lookup field is not the correct Life Sciences Cloud visit data model pattern. Option B is also not correct because it implies individual parent-level Visit records for every attendee, which would duplicate the overall group interaction. The correct structure is one parent Visit for the group interaction and three child Provider Visit records, one for each Healthcare Provider attendee.

The correct answer is B because the business requirement says the system must block additional distributions once the sample limit is met. In Salesforce Life Sciences sample management, sample limits are used to control how many samples can be distributed to HCPs based on rules such as product, time period, and visit limits. Salesforce Help describes sample management features as supporting efficient and compliant handling and distribution of drug samples, while sample limits are part of the setup used to govern sample distribution.

The distinction between enforcement types is important. A Warning allows the rep to continue after being alerted. A Threshold is typically used to identify when a limit is nearing or reaching a defined point, but it does not satisfy the requirement to prevent excess sample distribution. An Error is the strictest enforcement behavior because it stops the transaction when the configured limit would be exceeded.

Here, Cumulus Pharma needs hard compliance enforcement: maximum 5 units per HCP per calendar year and maximum 2 units per visit. Since the system must prevent field sales reps from exceeding those values, the consultant should set the sample limit enforcement type to Error . This ensures the disbursement cannot proceed when the annual or per-visit limit has already been reached.

=========

Option B is correct because Salesforce Life Sciences Cloud Medical Insights uses Medical Insight and Medical Insight Account configuration to capture and surface qualitative observations from engagements. Salesforce Help states that admins configure Medical Insight and Medical Insight Account objects by customizing the record page layout and creating required field sets. This directly matches the requirement: MSLs need to record qualitative observations and make those insights visible in the related account and visit context.

Medical Insights are intended to record observations or insights from HCP engagements, while the related Medical Insight Account object supports association of those insights with relevant accounts. By configuring layouts and field sets, the consultant controls which insight fields are available to users and how the data appears in the Life Sciences user experience. This is a standard configuration approach rather than a custom development pattern.

Option A is incorrect because feed tracking supports collaboration and Chatter-style record-feed updates; it does not configure the Medical Insights data-entry and display model. Also, “Product Insight” is not the standard object referenced for this Life Sciences Medical Insights setup. Option C is incorrect because assessment task flows and Medical Inquiry metadata are separate capabilities. Medical Inquiries manage HCP questions and responses, while Medical Insights capture field observations. Therefore, the consultant should customize the Medical Insight page layout and create field sets on Medical Insight and Medical Insight Account objects.

=========

Option C is correct because the requirement is product-specific and should be configured through Product Discussion Settings, not through a generic page-layout or Visit validation rule. Salesforce’s Life Sciences Cloud Visit Management data model includes Provider Visit Product Discussion as the object that represents products discussed during a visit, including key details about the product brand, therapeutic area, and related information. Salesforce also documents ProviderVisitProdDiscussion as representing additional notes or information about products discussed during a healthcare provider visit.

The question asks for a configuration that applies when a specific product, such as Immunexis, is discussed. Enabling Require Discussion in Product Discussion Settings for the product record is the most targeted standard configuration because it ties the requirement to that product’s visit discussion behavior.

Option A is not the best answer because a custom validation rule on Visit would have to inspect related product-discussion records and could become complex or unreliable for mobile visit submission behavior. Option B is also insufficient because making a Comments field required on the page layout would apply based on the layout, not specifically when Immunexis is discussed. It also would not necessarily enforce product-specific discussion requirements across all relevant visit submission paths. Therefore, the consultant should enable Require Discussion in Product Discussion Settings for the Immunexis product record.

=========

Option C is correct because Sample Inventory Management includes standard lock behavior for inventory operations based on status. The requirement is to prevent edits after a field sales rep submits inventory records such as transfers and adjustments. Salesforce Help references trigger handlers for Product Batch Item and Product Transfer objects, including ProductTransferLockHandler, which prevents modifications to Product Transfer records when the associated inventory operation is locked. This supports the standard Life Sciences pattern: the Inventory Operation reaches a locked status, and related inventory transaction records can no longer be modified.

Adding finalized status values to the Inventory Operation Locked Status list in Sample Inventory Settings is the appropriate administrative configuration because it tells the system which statuses should make the inventory operation locked. Once the record enters one of those statuses, the standard inventory lock handlers can enforce the restriction.

Option A is not the best answer because a restriction rule controls record visibility, not the complete GxP-style lock behavior for submitted inventory operations and related records. Option B is also not the best answer because a generic flow lock template is not the documented Sample Inventory Settings mechanism for locking inventory operations. Therefore, the consultant should configure the Inventory Operation Locked Status list with the finalized statuses that must prevent further edits.

=========

The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce’s Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.

The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.

Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings .

The correct answer is C: Perform audits of Inventory Count Assessment records user permission. In Life Sciences Cloud sample inventory management, Inventory Count Assessment records are used to support inventory count and audit processes. Salesforce documentation distinguishes between conducting or performing an audit and requesting an audit. The wording in the question asks which permission is needed for a user to conduct a self-audit of their inventory count. Because the action is to perform the audit, the required permission is the user permission that allows users to perform audits of Inventory Count Assessment records.

Option A is incorrect because the Life Sciences Field Sales Representative permission set alone should not be assumed to include every inventory audit capability by default. Salesforce Life Sciences sample inventory features use specific user permissions for different inventory audit actions, so the named permission is the safer and more precise answer. Option B is incorrect because “Request audits of multiple Inventory Count Assessment records” is related to submitting or requesting audits, especially peer-audit-style workflows, not personally conducting the self-audit. Salesforce Help notes that requesting a peer audit requires the Request Multiple Inventory Count Assessment Audits user permission, which confirms that request permission is separate from the permission to perform audits.

Therefore, for a self-audit where the user is actually conducting the audit activity, the correct permission is “Perform audits of Inventory Count Assessment records.”

The correct answer is C because reverse affiliation creation is handled by the AffiliationReciprocalHandler . Salesforce Help for Life Sciences trigger handlers identifies AffiliationReciprocalHandler as the handler that manages reciprocal affiliations. The same documentation notes behavior related to reciprocal affiliations and affiliation type handling, which directly matches the scenario where a newly created affiliation should automatically create the reverse relationship.

Affiliation Reverse Role Mapping defines how the relationship role should translate between the original and reciprocal records. For example, if an HCP is “Attending” at an HCO, the reverse relationship may show the HCO as “Employing” or otherwise related to the HCP, depending on the configured mapping. However, defining the mapping alone does not execute the automation. The trigger handler must be active so that when users create a new Affiliation record, Salesforce can generate the reciprocal Affiliation record using the configured reverse role mapping.

Option A, AffiliationUniquenessHandler , is incorrect because uniqueness logic prevents duplicate or invalid affiliation records; it does not create the reverse relationship. Option B, HardAffiliationHandler , is also incorrect because it is not the handler identified for reciprocal affiliation generation. Since the missing behavior is automatic creation of the reverse affiliation, the consultant must enable AffiliationReciprocalHandler .

The correct answer is A because User Reaction is the object designed to capture user feedback or reactions related to a Medical Insight. Salesforce’s Life Sciences Cloud Developer Guide identifies the UserReaction object and states that it can be associated with a medical insight through the source reference record relationship. This makes it the most appropriate object when users need to provide feedback on Medical Insights that have already been captured.

The scenario is not asking field reps to complete a formal assessment or collect HCP feedback. It asks for reps to provide feedback on the medical insights captured in the system. A User Reaction record supports this by allowing a user-level response to be connected back to the relevant Medical Insight record, preserving the relationship between the insight and the feedback.

Option B, Assessment Task , is incorrect because assessment tasks are typically used as structured tasks or questionnaires within planning, account management, or guided evaluation workflows. They are not the direct object for providing reactions to Medical Insights. Option C, Survey , is also incorrect because surveys are used to collect responses, often from customers or HCPs, through a survey experience. A survey would be unnecessary and less precise for internal rep feedback on an existing Medical Insight. Therefore, User Reaction is the correct object to recommend.

=========

The correct answer is B because the standard field that represents whether a received document is incoming or outgoing is Direction . Salesforce’s Life Sciences Cloud Developer Guide for the ReceivedDocument object lists direction values such as INCOMING — Incoming and OUTGOING — Outgoing , which directly matches the reporting requirement in the scenario.

The operations manager wants to analyze document volume based on whether consent forms are flowing into the organization from HCPs or being sent out to HCPs. That is a directional reporting requirement, not a document lifecycle or status requirement. Grouping the report by the Direction field allows the team to separate inbound consent forms from outbound documents using standard Salesforce data rather than creating a custom field or relying on interpretation.

Option A, Flow Type , is incorrect because the question is not asking about a business process type, document-processing flow, or automation path. It specifically asks for whether the document was incoming or outgoing. Option C, Document Status , is also incorrect because status would indicate where the document is in its lifecycle, such as received, processed, pending, or completed depending on configuration. Status does not define the direction of the document exchange. Therefore, the consultant should recommend grouping and filtering the report by the standard Direction field on Received Document.

=========

Option A is correct because routines are the Life Sciences Cloud capability intended for reusable visit schedules and recurring route patterns. Salesforce Help describes Customer Engagement features as including the ability to optimize daily schedules by showing key events and applying predefined routines on the calendar. This directly matches the requirement: field sales reps repeatedly visit the same groups of accounts across weekly routes or multi-day coverage patterns and want to reuse those planned schedules instead of rebuilding visits every time.

Routines support practical field planning because a rep can save a predefined pattern of planned visits and apply it later when the same route or schedule is needed. This is different from simply grouping accounts.

Option B is not the best answer because account lists help reps organize, filter, and target groups of accounts, but they do not by themselves preserve a reusable multi-day visit schedule. Account lists can help with planning, but they are not the direct solution for saving and reapplying a planned route. Option C is also incorrect because Activity Plans define strategic goals, targets, and activity expectations across a period. They align engagement activity to business objectives, but they are not designed to save and reapply recurring visit schedules. Therefore, the consultant should recommend creating a routine that saves the predefined set of visits and applying that routine as needed.

Option B, MedicalInsightSharingHandler, is correct because the requirement is about collaboration and access to medical insight records by users in the same territory. Salesforce Help describes the Medical Insights tab as enabling users to view their own insights as well as insights captured by users with the same profile within their territories. That means Life Sciences Cloud supports territory-based visibility for Medical Insights so that relevant field users can collaborate around insights collected from HCP engagements.

The key word in the question is “collaborate.” Collaboration requires record sharing, not merely record availability. MedicalInsightSharingHandler is the out-of-the-box configuration that aligns with sharing medical insight records across the appropriate users, such as reps associated with the same territory. MedicalInsightAvailabilityHandler is not the best answer because “availability” typically controls whether a feature, action, or object behavior is available in a given context; it does not directly describe record sharing between users. MedicalInsightTerritoryAvailabilityHandler is also not correct because the Salesforce-documented sharing behavior for Medical Insights is about viewing insights captured within the user’s territories, and the named handler that most directly supports that requirement is the sharing handler.

Therefore, when Cumulus Pharma wants field sales reps in the same territory to access and collaborate on relevant HCP medical insights, the correct out-of-the-box configuration is MedicalInsightSharingHandler.

The correct answer is C because Life Sciences Calendar can display visits where the user is not the owner but is included as an attendee or visitor. Salesforce Life Sciences Visit Management supports adding internal users as visitors to a visit so that colleagues participating in the same HCP interaction can be recorded and the visit can be shared with them. Salesforce also describes Life Sciences Calendar as a place to visualize and prioritize key activities, including visits and other events, and Trailhead explains that reps can view colleagues’ visits in shared calendars to coordinate engagement.

In this scenario, the rep bulk deleted several planned visits from their calendar. The two remaining visits are likely not visits owned and managed by the rep. Instead, they are visits owned by another user where the rep is included as an attendee. Because the calendar is configured to show attendee visits, those records continue to appear even after the rep deletes their own planned visits.

Option A is incorrect because the issue is not tied to the selected account list. Option B is plausible for some filtered-calendar behavior, but the key clue is that only some visits remain visible after bulk deletion. The standard Life Sciences explanation is that attendee visits can remain visible because they belong to a colleague and are displayed for collaboration. Therefore, the visits remain because the rep is added as an attendee.

=========

Option A is correct because Provider Activity Measure Type defines how engagement activities are measured and categorized in Activity Plans. Salesforce Help explains that an activity can be an interaction with a healthcare professional, such as a visit, and that a channel is the medium in which the interaction or activity occurs. This is exactly the requirement: Cumulus Pharma wants to distinguish email interactions from in-person visits so each channel can be counted separately against the field rep’s targets.

Salesforce Help for creating Activity Plans also states that admins should verify that a provider activity measure type has been created to track provider engagement activities. This confirms that Provider Activity Measure Type is the setup object used to define what kind of activity is being measured.

Option B, Provider Activity Goal, is not correct because it represents the target or goal assigned to providers or reps, such as six emails or three visits. It does not define the activity category itself. Option C, Provider Activity Plan Interaction, is also not the best answer because the question asks which configuration object defines the distinct interaction categories. The measure type is the categorization layer that can use Visit Channel, such as Email or In-Person, to count interactions separately. Therefore, Provider Activity Measure Type is the correct answer.

=========

Option A is correct because the Medical Inquiries record page setup depends on configuring the Inquiry Question Answer related-list experience with the correct field set. Salesforce Help for setting up the Inquiry record page for Medical Inquiries instructs admins to add tabs and Lightning components to the Inquiry page. It also specifically references the “Inquiry Question Answer” tab and requires the field set name for the Inquiry Question Answer field set. That means the field set must exist before the consultant can properly configure the Medical Inquiries record page component.

This requirement fits the business process described in the question. Field sales reps create and submit medical inquiry requests, and MSLs respond to the inquiry questions. The Inquiry Question Answer object supports the question-and-answer details used by the record page component, so the field set determines which fields appear to users when viewing or entering inquiry responses.

Option B is not the best answer because a support process is typically associated with Case status handling. While medical inquiries may be operationally similar to case management, the Salesforce Life Sciences setup step in this question is specifically about the Medical Inquiries record page. Option C is also not correct because syncing statuses between Case and Medical Inquiries is not identified as the prerequisite for configuring the page. Therefore, the consultant should first create the required field set for the Inquiry Question Answer object.

=========

The correct answer is B because the requirement is about making a Samples option appear in the Life Sciences mobile app sidebar, not about adding a related list to a Salesforce desktop page. Salesforce Help for setting up the Life Sciences Cloud mobile app specifically includes tasks for configuring the Visit Engagement Page and the Sidebar Menu . Salesforce also states that mobile app configuration changes are handled through the Life Sciences Commercial app’s Admin Console and mobile configuration areas, with metadata cache used to sync configuration to the mobile device.

The Samples tab is part of the mobile visit engagement experience. Enabling the relevant Samples sidebar setting in Mobile App Settings makes the Samples entry available in the sidebar so reps can record sample disbursements during a visit. This is the correct configuration approach because it controls the mobile navigation and visit sidebar behavior.

Option A is incorrect because adding the Product Disbursements related list affects a record page layout, but it does not create the mobile sidebar tab required by the field sales team. Option C is also incorrect because simply placing a Lightning web component on the Visit Lightning record page does not necessarily add a Samples entry to the Life Sciences mobile sidebar menu. The consultant should enable the Samples sidebar setting in Mobile App Settings.

=========

The correct answer is A because Remote Engagement email notifications depend on email templates configured for the relevant automated email invitation context/action. Salesforce Help for uploading and creating email templates in Life Sciences Cloud includes configuration fields for automated email invitation context and action. For a rescheduled or updated virtual visit, the email template must be configured so the automated email invitation action corresponds to the update event.

The scenario asks specifically about email notifications when virtual visits are rescheduled. A reschedule is an update to an existing visit invitation, not a new invitation and not a cancellation. Therefore, the consultant must ensure there is an email template whose Automated Email Invitation Action is set to Update . That template is then used by the Remote Engagement process when the visit details change and the HCP needs to receive the revised meeting information.

Option B is incorrect because configuring a handler around a visit status value such as “Rescheduled” is not the core template configuration required for the notification content and action. Option C may sound plausible because trigger handlers often support automation, but the question asks which configuration is required to send email notifications for rescheduled virtual visits. The action-specific email template is the necessary configuration. Therefore, the consultant should use an Email Template with Automated Email Invitation Action set to Update .

=========

The correct answer is B because Salesforce Life Sciences Cloud for Customer Engagement includes country-specific sample limit templates by default. Salesforce Help states that Life Sciences Cloud includes a generic sample limit template and several country-specific templates by default. These templates are intended to support sample-limit compliance where rules vary by country, including situations where statutory limits must be consistently applied without requiring administrators to rebuild complex legal rules from scratch.

In this scenario, Germany has strict legal limits on sample quantities that must apply to all HCPs. A default country-specific template is the best fit because it is designed to represent country-level sample compliance requirements in a reusable configuration. This approach reduces administrative maintenance, improves consistency, and helps ensure the sampling program follows local legal constraints.

Option A is incorrect because adding a new sample limit to custom metadata would require the admin or implementation team to manually maintain rule logic, which the requirement explicitly wants to avoid. Option C is also not the best answer because manually creating a sample limit rule in the Admin Console may work for custom business policies, but it is less appropriate when Salesforce provides a default country-specific template for statutory country rules. Therefore, the consultant should use the Default Country-Specific Template for Germany.

=========

The correct answer is C because Provider Cards are designed to consolidate key account information from multiple objects and fields into a single user-friendly account view. Salesforce Help describes Provider Cards in Life Sciences Cloud as consolidating an account’s information that is scattered across objects and fields, such as provider locations and related account information. Salesforce also describes the Provider Account Territory Info object as representing engagement data between an account and a user within an assigned territory, including account-territory context such as visit and engagement details.

The requirement is to display an indicator, not to filter accounts out of the card. Field reps need to see whether each account is a target or not. Adding an item group element to the Provider Card section and including the Targeted Account field from Provider Account Territory Info allows the template to display territory-specific targeting information. Visibility conditions can then show “Target” when the field value indicates the account is targeted and “Not Target” when it is not.

Option A is incorrect because filtering to show only targeted accounts would hide non-targeted accounts, but the requirement is to display both states. Option B is not the best answer because a repeater is used for repeating multiple related records, not for showing a single indicator from the account-territory information context. Therefore, the consultant should use an item group element with the Targeted Account field and visibility conditions.

=========

Option C is correct because Territory Product Quantity Allocations are designed to manage sample product distribution at the territory level. Salesforce Help explains that territory product quantity allocations and sample limits both help manage sample distribution to HCPs, but territory product quantity allocation is used when the business needs to allocate a defined product quantity to a territory. Salesforce’s setup guidance for Territory Product Quantity Allocations also states that Max Disbursement Limit Quantity is the maximum amount a sales rep can disburse in a given visit.

This directly matches the requirement. Cumulus Pharma wants to cap the total quantity of Immunexis 50mg available for a high-growth territory in the next quarter and also prevent reps from handing off more than 50 units in a single visit. A Territory Product Quantity Allocation record can store the territory-level allocated quantity, while Max Disbursement Limit Quantity enforces the per-visit disbursement cap.

Option A is incorrect because an Advanced Sample Limit Template focuses on account or provider-level sample limits, not the total allocation available to a territory. Option B is also incorrect because changing the Life Sciences Marketable Product globally would affect the entire organization, not just the high-growth territory. Therefore, the correct recommendation is to create a Territory Product Quantity Allocation record and set the per-visit max disbursement limit to 50.

=========